Search

Your search keyword '"Franzè, Maria Stella"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Franzè, Maria Stella" Remove constraint Author: "Franzè, Maria Stella"
35 results on '"Franzè, Maria Stella"'

Search Results

2. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

4. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

5. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

7. Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

9. FRI-456 Characterization of the intratumoral immune microenvironment of hepatocellular carcinoma before selective intrahepatic radiation therapy (SIRT) and study of its prognostic value on response to treatment

11. SAT-386-YI Characterization of intrahepatic immune microenvironment in liver biopsies across different phases of untreated HBeAg-negative patients

12. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

15. Hepatitis Delta Virus and Hepatocellular Carcinoma.

16. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

17. Natural Course of COVID-19 and Independent Predictors of Mortality

18. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

19. Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review

20. Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance

21. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

22. Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia

25. Monofocal hepatocellular carcinoma: How much does size matter?

26. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

27. Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate

28. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules

29. Outcome of cutaneous psoriasis in hepatitis C virus‐infected patients treated with Direct‐Acting Antiviral therapy

30. Outcome of cutaneous psoriasis in hepatitis C virus‐infected patients treated with Direct‐Acting Antiviral therapy.

31. Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy.

32. Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

34. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

35. Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review.

Catalog

Books, media, physical & digital resources